Results 141 to 150 of about 362,184 (267)

Role of remdesivir for the treatment of COVID‐19 in patients with hematologic malignancy—A narrative review and expert opinion

European Journal of Clinical Investigation, EarlyView.
Created in BioRender. Ghezzi, S. (2025) https://BioRender.com/q1lticg. Abstract Background COVID‐19 remains a potentially severe condition for immunocompromised individuals, such as patients with hematologic malignancy. These patients are at increased risk of progressing to severe–critical or prolonged COVID‐19.
Malgorzata Mikulska, Matteo Bassetti, Alessandro Busca, Valeria Cento, Maddalena Giannella, Michele Bartoletti   +5 more
wiley   +1 more source

Permissiveness of American bison to infection with severe acute respiratory syndrome coronavirus-2. [PDF]

Sci Rep
Palmer MV, Buckley A, Cassmann ED, Olsen SC, Nielsen DW, Putz EJ, Seger H, Chandler JC, Boggiatto PM.   +8 more
europepmc   +1 more source

Commentary: Pneumatocele and cysts in a patient with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection—yet another new complication associated with coronavirus disease 2019 (COVID-19) [PDF]

, 2020
Danny Ramzy
openalex   +1 more source

Nationwide estimates of SARS‐CoV‐2 infection fatality rates and numbers needed to vaccinate for COVID‐19 vaccines in 2024 in Austria

European Journal of Clinical Investigation, EarlyView.
In 2024, Austria's infection fatality rate (IFR) for SARS‐CoV‐2 was .048%, indicating a low COVID‐19 mortality risk. Using literature‐based vaccine effectiveness estimates, numbers needed to vaccinate (NNV) to prevent one death and one life‐year saved (LYS) were extremely high across all age groups, except among the very old.
Uwe Riedmann, Martin Sprenger, John P. A. Ioannidis, Stefan Pilz   +3 more
wiley   +1 more source

Seroprevalence of Immunoglobulin M and G antibodies to severe acute respiratory syndrome coronavirus 2 infection in Iwo, Nigeria. [PDF]

BMC Infect Dis
Nejo YT, Oladosu OO, Olatubi MI, Owoseni AA, Dahunsi SO.   +4 more
europepmc   +1 more source

Type I interferon signalling and interferon‐responsive microglia in health and disease

The FEBS Journal, EarlyView.
Recent insights reveal that type I interferon (IFN‐I) signalling plays critical roles in the nervous system beyond antiviral defence. Dysregulated IFN‐I activity is increasingly linked to neurological dysfunction and neurodegeneration, with microglia as central mediators. This review explores the broader impact of IFN‐I signalling on the nervous system
Jose P. Lopez‐Atalaya, Aysha M. Bhojwani‐Cabrera   +1 more
wiley   +1 more source

Severe acute respiratory syndrome coronavirus 2 infection and West Nile encephalitis in a patient with chronic kidney disease. [PDF]

J Crit Care Med (Targu Mures)
Andrejkovits VA, Asztalos AI, Bodnar NI, Zaharia-Kezdi EI, Vasiesiu AM.   +4 more
europepmc   +1 more source

Behind the scenes: how the EMILIN/Multimerin family shapes the cancer landscape

The FEBS Journal, EarlyView.
The EMILIN/Multimerin family members regulate key hallmarks of cancer—including apoptosis, angiogenesis, metastasis, and tumor microenvironment remodeling. As indicated, their function in immune evasion, drug resistance, and metabolic reprogramming remains largely unexplored.
Evelina Poletto, Naike Casagrande, Emanuele Di Siena, Greta Carobolante, Lucrezia Camicia, Giorgia Schinello, Samanta Muzzin, Enrica Timis, Paola Spessotto, Maurizio Mongiat   +9 more
wiley   +1 more source

Wastewater-based surveillance for severe acute respiratory syndrome coronavirus 2 variants in Gwangju, Republic of Korea. [PDF]

Front Microbiol
Lee C, Park J, No JS, Kim J, Seo J, Kim D, Kim IH, Kim EJ.   +7 more
europepmc   +1 more source

The role of ozone therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19)

, 2023
Biyan Nathanael Harapan, Triswan Harapan
openalex   +1 more source